YRD treatment in this STC mouse model was effective, possibly via the restoration of the SCF/c-kit pathway, increase in the ICC count, and enhancement of ICC function by increasing [Ca2+]i. The gene discussed is KIT; the disease is intrahepatic cholangiocarcinoma.